Google Ads for supplement brands: compliance-first, LTV bidding, and 2.5-3.5x ROAS

How does Google Ads work for supplement brands?

Google Ads for supplement brands starts with compliance, not campaigns. Health claims like "cures joint pain" or "treats anxiety" trip GMC policy filters and can get an account suspended within 48 hours of launch. Every health claim gets rewritten to a use-case description first - "supports joint mobility", "promotes calm focus". Once the feed is clean, LTV bidding feeds subscription reorder signals to Smart Bidding so it optimizes for long-term value instead of a first-order ROAS that looks unprofitable on its own.

Supplements are the tightest compliance vertical in ecom Google Ads. There is no other category where a single product title can end the account in two days. And there is no other category where the first-order ROAS number is so deliberately misleading.

Most supplement brands we inherit are either suspended (health claims in the feed), or scaling toward the wrong target (optimizing first-order ROAS as if there is no reorder). Both problems have the same root: the account was built by someone who treated supplements like any other ecom vertical.

They are not.

First-order ROAS band

2.5-3.5x

LTV ROAS (subscription)

5-8x+

Time to GMC suspension (bad claims)

48 hrs

Reorder rate (strong supplement brands)

40-65%

Why supplements break standard Google Ads setups

Every ecom vertical has its quirks. Supplements have two that make generic agency setups fail immediately.

Health claims are a landmine, not a technicality. Google's policy for health and supplements is not a gray area. Claims that describe a medical action - treat, cure, prevent, heal - trigger immediate review. Claims that reference specific medical conditions in the context of treatment will suspend the account, not just disapprove the listing. This is different from beauty, where claim compliance is mostly a listing-level issue. In supplements, the account-level risk is real.

The distinction that matters: "supports joint mobility" is a use-case claim. "Cures joint pain" is a medical claim. The first one is allowed. The second one gets the account flagged within 48 hours.

First-order ROAS is the wrong number to optimize. A supplement brand selling a €35 joint support capsule with a 50% reorder rate looks very different at month one vs month six. At month one, first-order ROAS might be 1.8x. At month six, with three reorders per customer counted, LTV ROAS is 6-8x. Optimizing Smart Bidding against first-order ROAS alone tells the algorithm the account is unprofitable and it scales back accordingly.

This is the most common failure mode on supplement accounts. The brand is actually printing money on LTV. The account setup is signaling that it is losing money. Smart Bidding believes the signal.

The compliance audit before any campaign goes live

The compliance order of operations is not optional and it is not a later task.

Step one: audit every product title and description. Pull the full catalog. Check every title and description for medical claims, condition references, and unsupported efficacy language. This is the step most brands skip. They find out the hard way when GMC suspends them.

Step two: rewrite claims to use-case language. This is where most supplement brands need help, because the natural marketing language for supplements is claim-first. Here are two concrete before/after rewrites to use as templates.

Before: "ZinaCure Joint Pain Formula - clinically proven to reduce inflammation and cure arthritis pain" After: "Zina Joint Support Formula - supports mobility and flexibility, formulated for active adults"

The rewrite keeps the product purpose clear. It removes the medical-action language and the unsupported "clinically proven" claim. The product page can say more - but the feed title and description need to stay in the use-case lane.

Before: "AnxioCalm - treats anxiety and depression naturally, proven to calm the nervous system" After: "AnxioCalm - promotes calm focus and relaxation, naturally formulated with ashwagandha and L-theanine"

Same product. Same intent. The second version surfaces the ingredient (good for shopping match) and uses benefit language instead of medical-condition language. It will not trip GMC. The first version will.

Step three: geo-split US from EU. If the supplement sells into the US, the compliance standard is tighter. FDA drug-language rules classify a product as a drug if the marketing language implies medical treatment. Even claims that clear in Germany can get a US-targeted campaign suspended. The fix is a geo-split setup where US traffic sees FDA-safe copy and EU traffic sees the full EU-compliant claim set.

Step four: document what changed and why. Feed audits need a record. When GMC does flag a listing, you need to know exactly what language was there and what it was changed to. Without that record, you are doing the audit again from scratch every time.

LTV bidding for subscription supplement brands

The compliance audit removes the landmines. LTV bidding is where the real margin unlocks.

Setting up the conversion actions

Every supplement account that sells on subscription needs three conversion actions in Google Ads:

1. First purchase - standard purchase conversion, value = actual first-order revenue
2. First reorder - triggered when a customer places their second order, value = average LTV increment from becoming a repeating buyer
3. Active subscriber - triggered at 90-day active subscriber status, value = predicted 12-month LTV minus first-order revenue already counted

These three signals together tell Smart Bidding what a new customer is actually worth, not just what the first order is worth.

What the bidding targets look like

A supplement brand with a €35 first-order product and 55% reorder rate at 60 days might look like this:

• First order value: €35
• First reorder (triggers at 60 days): assign an additional €45 value signal (conservative mid-LTV)
• Active subscriber at 90 days: assign an additional €80 value signal (representing the next 12 months at ~50% probability of staying active)

With these signals in place, Smart Bidding is no longer trying to hit a 2.5x ROAS on a €35 order. It is optimizing for a customer worth €160 in LTV. The bidding target moves accordingly, and Smart Bidding can afford to pay more for the right buyer.

Micro-conversion goals during the learning phase

New supplement accounts need conversion volume to learn. A product with 30 conversions per month at first-order level will not give Smart Bidding enough signal. In that case, add micro-conversions: add-to-cart, checkout initiation, subscription page view. These do not replace the purchase conversion goal, but they give the algorithm enough signal to optimize while the account scales to sufficient purchase volume.

Performance Max structure for supplement brands

Campaign architecture

Tier A - high-LTV subscription SKUs. Products with proven reorder rates above 40%. tROAS target built on LTV signal, not first-order. These are the products that actually run the economics of the brand. Champion asset groups with their own creative, ingredient-forward copy, and benefit language that passed the compliance audit.

Tier B - high-margin single-purchase SKUs. One-off supplement purchases at high margin (€40+ per unit, 60%+ gross margin). tROAS targeting 3x+ on first-order, no LTV signal. These need their own asset group so the LTV bidding from Tier A does not distort their signal.

Tier C - entry SKUs and samplers. Low-AOV first-purchase entry points designed to convert browsers into the subscription funnel. These run at a deliberate low ROAS target on first order - because the LTV from customer acquisition is the real goal. Never put these in the same asset group as Tier A without separate budget controls.

Search for bottom-funnel intent

Supplement buyers search by ingredient, health goal, and product comparison. Performance Max alone misses the high-intent bottom-funnel queries where conversion rates are 3-5x higher than category browsing.

Build Search campaigns for:

• Ingredient-specific queries: "ashwagandha supplement", "magnesium glycinate 400mg", "omega 3 high strength"
• Health-goal queries: "joint support supplement for runners", "sleep supplement adults", "energy supplement no caffeine"
• Brand-plus-intent queries: competitor names, branded ingredient queries, "best [ingredient] supplement"

These queries convert at 5-8% in a well-structured Search campaign. PMax lumps them into general shopping traffic. Pull them out.

	Default Setup	Optimal Setup
Compliance audit	None / on suspension	Pre-launch, every SKU
Conversion signal	First-order only	First order + reorder + LTV
US / EU copy	One global version	Geo-split with FDA-safe US copy
Campaign split	1 (all supplements)	Subscription + margin + entry tiers
Search campaigns	Not running	Ingredient + goal queries
tROAS target	First-order ROAS	LTV-based ROAS for subscription SKUs
Micro-conversions	Not set up	Add-to-cart + checkout initiation
Brand defence	Not running	Brand Search to block competitor bidding

Feed changes that compound on supplement accounts

Custom label: LTV tier

The most important custom label on a supplement account is not margin. It is LTV.

Tag every SKU with a ltv_tier custom label:

• subscription_core - proven reorder rate 40%+ at 60 days
• high_margin_single - strong margin, low reorder rate
• entry_acquisition - designed to convert browsers into the subscription funnel
• tail - low margin, low reorder, low strategic value

Feed this into listing-group rules for each campaign tier. The engine then bids correctly from day one instead of learning it over 90 days of wasted signal.

Title rewrites for ingredient and goal signals

Supplement feed titles are often the brand name plus product name, which matches nothing. Rewrite for the search query.

Before: "VitaMax Joint Formula - 60 capsules" After: "Glucosamine & Chondroitin Joint Support Supplement, 60 Capsules, High Strength, Adults"

The ingredient-forward title matches how supplement buyers actually search. "Glucosamine supplement 60 capsules" gets clicked. "VitaMax Joint Formula" gets ignored unless the buyer already knows the brand.

This one change, applied to the top 80 SKUs in the catalog, is worth more than most campaign optimizations. We do it on day one for every supplement account we take on.

GMC disapproval clearance

When disapprovals hit (and they will on supplements, even with the pre-launch audit), three issues account for 80% of them:

Health claims in supplementary feed fields. The product description was cleaned up. The GMC additional attributes were not. Pull ads_redirect, description_en_AU variants, and any custom feed fields and check them too.

"Clinically proven" without a landing-page study link. If the product page does not link to a published study, remove the claim from the feed. "Formulated by nutritionists" is compliant. "Clinically proven efficacy" without a study is not.

Condition-referencing titles. A product called "DiabeCare Blood Sugar Support" is borderline. A product called "DiabeCare - treats high blood sugar" is an immediate flag. Strip the condition from the title and move to ingredient and goal language.

ROAS band and what it actually means

2.5-3.5x on first-order is the correct ROAS band for supplements. This number gets called out as low by brands who see fashion at 3-4x or jewelry at 3.5-5x. The comparison misses the point.

Supplement margin on a well-run brand is 65-75% gross. A 2.5x ROAS on a 70% gross margin product is a 30% net ROAS contribution after ad spend. Fashion running at 3.5x ROAS on 45% gross margin is a similar or lower net contribution.

The first-order ROAS is the floor. For every 10 customers a supplement brand acquires at 2.5x ROAS, 5-6 of them reorder at 60 days. At 90 days, 3-4 are active subscribers. By month six, the cohort LTV makes the first-order cost of acquisition look cheap.

Optimize for the LTV number. Report both. Never optimize for first-order ROAS alone.

What this means for your supplement brand this quarter

If your supplement account has not had a compliance audit, that is the first move. Pull every product title and description. Check for medical claims, condition references, and unsupported efficacy language. Rewrite to use-case language. Do this before the first campaign goes live.

If you are selling into the US and running one global campaign, geo-split before the next billing cycle. US FDA compliance is tighter than EU standards. The account-level suspension risk from drug-language violations is not worth the operational simplicity of one campaign set.

If you are optimizing for first-order ROAS and your subscription reorder rate is above 30%, you are bidding on the wrong number. Set up the three conversion actions (first purchase, first reorder, active subscriber) and switch to LTV-based bidding targets.

For the self-serve playbook, the Google Ads eCom Lab on Skool covers supplement compliance in detail - claim rewrite templates, LTV bidding setup, geo-split structure.

For done-for-you on a supplement brand, the Google Ads agency page is where to start. For how the same compliance thinking applies to beauty brands with cosmetic claim issues, see the beauty Google Ads playbook. For pet brands with supplement-adjacent products like calming chews and joint treats, see the pet brand Google Ads playbook.

Across all seven ecom verticals we operate, supplements have the lowest first-order ROAS and the highest LTV multiplier. The two numbers together make it one of the strongest economic models in the category. The brands that understand that - and build their bidding strategy around it - win.

The brands that chase a 4x first-order ROAS on a subscription supplement product are bidding against themselves.

First-order ROAS was 2.1x and we were panicking. LTV at 90 days was 5.8x. We were profitable the whole time. We just did not know how to read the numbers.

Supplement Google Ads is a patience game with a compliance tax at the start. Get the compliance right once. Build the LTV signal in from day one. Let Smart Bidding optimize for the number that actually reflects the economics. Then the 2.5-3.5x first-order ROAS stops looking like a problem and starts looking like what it actually is - the entry price for a subscription-economics business that compounds over time.